Prof. Dr. AHMET OĞUZ ADA

Yayın Ağı

Makaleler 17

1. **Investigation of CYP1B13 and CYP1B14 polymorphisms in a Turkish population**

Kargın Solmaz F. Ö., Akgöl J., Becit Kızılkaya M., Ada A. O.

Health Sciences Quarterly , cilt.2, sa.3, ss.127-138, 2022 (Hakemli Dergi)

2. The roles of ANRIL polymorphisms in periodontitis: a systematic review and meta-analysis

ÖZTÜRK A., ADA A. O.

CLINICAL ORAL INVESTIGATIONS , cilt.26, sa.2, ss.1121-1135, 2022 (SCI-Expanded, Scopus)

3. The roles of ANRIL polymorphisms in periodontitis: a systematic review and meta-analysis

Öztürk A., Ada A. O.

CLINICAL ORAL INVESTIGATIONS , cilt.26, sa.2, ss.1121-1135, 2022 (SCI-Expanded)

4. Investigation of GSTM1 and GSTT1 polymorphisms in obesity patients under bariatric surgery Bariatrik cerrahi olmuş obezite hastalarında gstm1 ve gstt1polimorfizmlerininaraştırılması

Ünsal A., Buluş H., Dirican O., Oğuztüzün S., Öztürk D., Cihan M., et al.

Fabad Journal of Pharmaceutical Sciences , cilt.46, sa.2, ss.139-146, 2021 (Scopus) Sürdürülebilir Kalkınma

5. Cytochrome P450 1B12 Gene Polymorphism in a Turkish Population

ADA A. O., KARGIN SOLMAZ F. Ö.

FABAD Journal of Pharmaceutical Sciences , cilt.44, sa.3, ss.205-214, 2019 (Scopus)

6. Expression of CYP and GST in human normal and colon tumor tissues

Bulus H., Oguztuzun S., Simsek G. G., KILIÇ M., ADA A. O., Gol S., et al.

BIOTECHNIC & HISTOCHEMISTRY , cilt.94, sa.1, ss.1-9, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Cytochrome P450 1B1∗2 gene polymorphism in a cturkish population

Kargin Solmaz F. O., ADA A. O.

Fabad Journal of Pharmaceutical Sciences , cilt.44, sa.3, ss.215-218, 2019 (Scopus) Sürdürülebilir Kalkınma

8. Polymorphisms and Protein Expressions of Glutathione S-Transferase M1 and T1 in Non-Small Cell Lung Cancer

KILIÇ M., ADA A. O., OĞUZTÜZÜN S., Demirag F., ÇELİK S., Bicakcioglu P., et al.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.14, sa.3, ss.237-242, 2017 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

9. Cytochrome P-450 Polymorphisms and Clinical Outcome in Patients with Non-Small Cell Lung Cancer

Iscan M., ADA A. O.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.14, sa.3, ss.319-323, 2017 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

10. Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients

Karacaoglan V., ADA A. O., Bilgen S., Cetinkaya G. T., Soydas E., Kunak C. S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.2, ss.554-562, 2017 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

11. **Association between the TP53 and CYP2E1*5B gene polymorphisms and non-small cell lung cancer**

ADA A. O., Bilgen S., Karacaoglan V., Kunak C. S., Soydas E., Alpar S., et al.

ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY , cilt.67, sa.4, ss.311-316, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Prognostic Significance of Caspase 3 BCL 2 p53 and GSTP1 Expressions in Lung Adenocarcinoma

OĞUZTÜZÜN S., ADA A. O., KILIÇ M., Çakır E., yılmaz a.

FABAD Journal of Pharmaceutical Sciences , cilt.38, sa.2, ss.83-89, 2016 (Scopus)

13. CYTOGENETIC DAMAGE IN TURKISH COKE OVEN WORKERS EXPOSE l TO POLYCYCLIC AROMATIC HYDROCARBONS: ASSOCIATION WITH CYP1A1, CYP1B1, EPHX1, GSTM1, GSTT1, AND GSTP1 GENE POLYMORPHISMS

ADA A. O., Demiroglu C., Yilmazer M., SÜZEN H. S., Demirbag A. E., Efe S., et al.

ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY , cilt.64, sa.3, ss.359-369, 2013 (SCI-Expanded, Scopus)

14. Cytogenetic Damage in Turkish Coke Oven Workers Exposed to Polycyclic Aromatic Hydrocarbons: Association with CYP1A1, CYP1B1, EPHX1, GSTM1, GSTT1, and GSTP1 Gene Polymorphisms

ADA A. O., demiroğlu c., yılmazer m., SÜZEN H. S., Demirbağ A., Efe S., et al.

Arh Hig Rada Toksikol , cilt.64, sa.3, ss.359-369, 2013 (Hakemli Dergi)

15. ASSOCIATION BETWEEN GLUTATHIONE S-TRANSFERASE OMEGA 1 A140D POLYMORPHISM IN THE TURKISH POPULATION AND SUSCEPTIBILITY TO NON-SMALL CELL LUNG CANCER

Ada T. G., ADA A. O., Kunak S. C., Alpar S., Gulhan M., Iscan M.

ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY , cilt.64, sa.2, ss.247-253, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Association between GSTM1, GSTT1, and GSTP1 polymorphisms and lung cancer risk in a Turkish population

ADA A. O., Kunak S. C., Hancer F., Soydas E., Alpar S., Gulhan M., et al.

Molecular Biology Reports , cilt.39, sa.5, ss.5985-5993, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Cytochrome P450 (CYP) and glutathione S-transferases (GST) polymorphisms (CYP1A1, CYP1B1, GSTM1, GSTP1 and GSTT1) and urinary levels of 1-hydroxypyrene in Turkish coke oven workers

Ada A. O., Yilmazer M., Suzen S., Demiroglu C., Demirbag A. E., Efe S., et al.

GENETICS AND MOLECULAR BIOLOGY , cilt.30, sa.3, ss.511-519, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 10

1. INVESTIGATION OF GST ISOENZYMES AND APOPTOTOTIC EFFECT IN MCF7 HUMAN BREAST CANCER CELL LINE BEFORE AND AFTER DOXORUBICIN TREATMENT

OĞUZTÜZÜN S., KAYA KOÇDOĞAN A., ŞİMŞEK G., GÜRBÜZ N., TÜRK M., İŞGÖR Y. G., et al.

12 th International symposium on Pharmaceutial sciences, Ankara, Türkiye, 26 - 29 Haziran 2018, ss.413, (Özet Bildiri) Sürdürülebilir Kalkınma

2. EXPRESSIONS OF GSTS1, GSTZ1 IN HUMAN COLON TUMORTISSUES

ADA A. O., Koçdoğan A. K., OĞUZTÜZÜN S., ŞİMŞEK G., KILIÇ M., Irmak Y., et al.

the 2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

3. IMMUNOHISTOCHEMICAL DEMONSTRATION OF EXPRESSIONSOF CYPS AND GSTS IN HUMAN TUMOR AND NON TUMORTISSUES OF NON-SMALL CELL LUNG CANCER

KILIÇ M., OĞUZTÜZÜN S., ADA A. O., BIÇAKÇIOĞLU P., DEMİRAĞ F., ÇELİK S., et al.

the 2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

4. INVESTIGATION OF GST ISOENZYMES AND APOPTOTOTIC EFFECT IN DLD-1 HUMAN COLON CANCER CELL LINE BEFORE AND AFTER 5-FLUOROURACIL TREATMENT

ADA A. O., GÜRBÜZ N., KAYA KOÇDOĞAN A., OĞUZTÜZÜN S., ŞİMŞEK G., TÜRK M., et al.

2. INTERNATIONAL GAZI PHARMA SYMPOSIUM, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

5. THE PROTEIN EXPRESSIONS OF DRUG/XENOBIOTICMETABOLIZING ENZYMES IN HUMAN COLON TUMOR ANDNON-TUMOR TISSUES

ADA A. O., OĞUZTÜZÜN S., Kaygın P., KILIÇ M., ŞİMŞEK G., BULUŞ H., et al.

the 2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

6. **CYP1B12 and CYP1B13 polymorphisms and clinical outcome in non-small cell lung cancer patients**

Iscan M., ADA A. O., Guler A., Kunak C. S., Gulhan M.

53rd Congress of the European-Societies-of-Toxicology (EUROTOX), Bratislava, Slovakya, 10 - 13 Eylül 2017, cilt.280, (Özet Bildiri) Sürdürülebilir Kalkınma